NuGen Medical Devices EBIT

The latest EBIT for NGMDF is $-4.5M as of June 2026. That compares with $-740K in the prior-year period — down 501.2% year over year. That is above the sector sector average of $-25M. Investors often review this figure alongside NuGen Medical Devices's historical trend and sector peers before judging valuation or financial health.

Over the past year, NGMDF's EBIT moved from $-740K to $-4.5M — a 501.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in NuGen Medical Devices's operating scale or balance-sheet position.

Against its sector companies, NGMDF currently prints $-4.5M for EBIT, while the sector average sits near $-25M. That is roughly 82.4% above the sector mean. Large gaps often invite a closer look at NuGen Medical Devices's growth, margins, and balance sheet.

A EBIT figure of $-4.5M for NGMDF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-25M. Explore the charts below for those layers of context.

After noting NGMDF's EBIT ($-4.5M), review year-over-year change from $-740K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.